COVID-19: This Indian company can introduce vaccine in the market by July, the price will be Rs 1000

The Serum Institute of India says that if everything goes well, bulk production of vaccine of Covid 19 will start from July.

To fight the corona virus, pharmaceutical companies from countries around the world are engaged in the use of vaccines. In this sequence, an Indian pharmaceutical company has shown great hope to the world. India's pharma company Serum Institute of India says that if everything goes well, bulk production of Covid 19 vaccine will start from July. According to Khaleej Times, the company says that the human trial of vaccine is going on. However, there is still some process left in this. The company has also said that the cost of this vaccine will be 1000 rupees in Indian currency.

In India, the Pune-based Serum Institute of India is among the leading companies in the world that manufactures vaccines. The company also exports the vaccine on a large scale. The company says that to make this vaccine, the company is setting up a plant by spending a total of Rs 600 crore. Where work is going on on this vaccine. By the end of July, the company can start its bulk production. However, at the domestic level, regulatory approval from the Indian Council of Medical Research and other agencies will be necessary.

loading...

First aim to supply in India

The CEO of Serum Institute of India, Adar Poonawala told Khaleej Times that if the company has enough vaccine after production, they will also export it to the needy countries. But his first priority will be India.

Price will be 1000 rupees

He informed that the market price of vaccine will be 1000 rupees. The company is hoping to take it to 4 crore doses by September, keeping the initial target of 50 million doses per month from July. According to the company, its trial has started from April 23. Serum Institute of India is a Pune based company which is the largest producer of vaccine.

The Serum Institute is included in the Oxford Vaccine Group. The company's main plant is in Pune. Apart from this, there are 2 big plants in Netherlands and Czech Republic. The company also has partnerships with some foreign companies. The company says that whenever a vaccine is made, it is trialled in a few steps. Only after that it is launched in the market.